lung transplantation is the only treatment for end stage lung cystic fibrosis (CF) disease after maximal therapy. Chronic lung infections in CF patients lead to persistent activation of effector T-cells, in turn causing exacerbated inflammation, tissue damage and. ultimately, lung failure. Recent evidence showed that TH1/17 cells, secreting signature IFN-y and IL-17 proinflammatory cytokines,can worsen inflammatory responses and contribute to CF pathogenesis. However, the pathogenic role of Th1/17 cells in CF-Ltx recipients, has never been characterized.
Pathogenetic lung-infiltrating TH1/17 cells as new target in cystic fibrosis lung transplantation recipients : preliminary results / M. Paroni, A. Bibi, G. Leccese, R. Macchi, A. Berni, L. Morlacchi, V. Musso, M. Nosotti, P. Landini, A. Palleschi. - In: TRANSPLANT INTERNATIONAL. - ISSN 0934-0874. - 32:suppl. 2(2019), pp. -375. (Intervento presentato al 19. convegno ESOT Congress tenutosi a Copenhagen nel 2019).
Pathogenetic lung-infiltrating TH1/17 cells as new target in cystic fibrosis lung transplantation recipients : preliminary results
A. Bibi;V. Musso;M. Nosotti;P. Landini;A. Palleschi
2019
Abstract
lung transplantation is the only treatment for end stage lung cystic fibrosis (CF) disease after maximal therapy. Chronic lung infections in CF patients lead to persistent activation of effector T-cells, in turn causing exacerbated inflammation, tissue damage and. ultimately, lung failure. Recent evidence showed that TH1/17 cells, secreting signature IFN-y and IL-17 proinflammatory cytokines,can worsen inflammatory responses and contribute to CF pathogenesis. However, the pathogenic role of Th1/17 cells in CF-Ltx recipients, has never been characterized.File | Dimensione | Formato | |
---|---|---|---|
ESOT 2019 (pathogenetic lung infiltrating...).pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
1.3 MB
Formato
Adobe PDF
|
1.3 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.